<DOC>
	<DOCNO>NCT02648152</DOCNO>
	<brief_summary>Multicenter observational study validate POLARSTEM™ state-of-the-art implant term radiographic , clinical performance long-term survivorship .</brief_summary>
	<brief_title>Polarstem Cementless Hip Stem</brief_title>
	<detailed_description>The goal multicenter clinical observation validate short- , mid- , long-term outcome ( efficacy safety ) POLARSTEM™ . Efficacy evaluation : - Evaluation function , range motion ( ROM ) pain assess Harris Hip Score , Hip disability osteoarthritis outcome score ( HOOS ) [ 7 , 8 ] , extension Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) . - Radiographic change define radiolucent line , osteolysis , hypo- hypertrophy , implant loosening migration Safety evaluation : - Intra- perioperative device-related adverse event ( AE ) complication discharge - Postoperative AE 10 year</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patient general medical contraindication surgery Informed consent participate MCO sign patient Routine radiographic assessment possible Patient likely comply study followup requirement Primary total hip replacement ( THR ) affect side , unilateral bilateral Previously fail endoprosthesis /or THR component relevant hip History infection affect joint ; systemic infection Grossly insufficient femoral acetabular bone stock involve hip Charcot joint disease severe neurosensory deficit Severe spinal disorder Age patient date surgery &gt; 75 year High comorbidity Cemented acetabular cup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>